SCHEMBL4900071

SCHEMBL4900071

CCc1ccc(SN(CC)S(=O)(=O)c2ccc(CC)c(C(=O)OC)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
TSHR P16473 1/20 0.49
HPGD P15428 1/20 0.37
CA2 P00918 3/20 0.36
PSMD14 O00487 1/20 0.36
MMP2 P08253 1/20 0.36
POLB P06746 1/20 0.36
LMNA P02545 2/20 0.35
PTPN1 P18031 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
RORC P51449 1/20 0.35
KDM4E B2RXH2 3/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPK1 P28482 1/20 0.35
HCRTR2 O43614 1/20 0.34
BMP1 P13497 1/20 0.34
MAPT P10636 1/20 0.34
PTPRC P08575 1/20 0.34
PTPRG P23470 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894507 0.90 ALDH1A1 (0.48) ALDH1A1TSHRHPGDPSMD14MMP2
SCHEMBL4898117 0.89 ALDH1A1 (0.40) ALDH1A1TSHRHPGDLMNAKDM4E
SCHEMBL4902927 0.89 ALDH1A1 (0.48) ALDH1A1TSHRHPGDCA2POLB
SCHEMBL4906088 0.88 ALDH1A1 (0.45) ALDH1A1TSHRLMNASMN1; SMN2RORC
SCHEMBL4903910 0.87 ALDH1A1 (0.46) ALDH1A1TSHRLMNASMN1; SMN2KDM4E
SCHEMBL4906314 0.85 ALDH1A1 (0.44) ALDH1A1TSHRPSMD14MMP2POLB
SCHEMBL4905008 0.84 TSHR (0.42) ALDH1A1TSHRHPGDCA2POLB
SCHEMBL4902492 0.81 ALDH1A1 (0.40) ALDH1A1TSHRHPGDPOLBLMNA
SCHEMBL4905613 0.81 ALDH1A1 (0.48) ALDH1A1TSHRHPGDCA2SMN1; SMN2
SCHEMBL4895549 0.80 ALDH1A1 (0.39) ALDH1A1TSHRHPGDPSMD14MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HPGD 696/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.